Clinical Implications of Minimal Residual Disease Detection in Infants With KMT2A-Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 Protocol The cluster-randomized trial included ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results